More than 10,000 kids have already signed up for a dose of the COVID-19 vaccine, just one day after the shot became available at UPMC, doctors announced Friday.
Many of the vaccinations will be given at pediatricians’ offices in the UPMC network, said Dr. Alejandro Hoberman, president of UPMC Children's Community Pediatrics.
Although children are less likely to develop serious symptoms from the disease, the shot is a critical part of stopping the virus’ spread, particularly from young kids to older adults or other vulnerable people.
“If there is one silver lining to this horrible pandemic, it is probably that poor outcomes or deaths for children with COVID-19 are lower than for older adults,” Dr. Hoberman said.
There have been approximately 6.5 million cases of COVID-19 confirmed in children under 18 years in the U.S., according to the American Academy of Pediatrics. While CDC data says more than 800 children have been confirmed to have died from the virus, Dr. Hoberman said it’s still too many, especially when vaccines are widely available.
“We need to understand that this is a vaccine-preventable disease, like measles or polio and many other diseases that affect children,” he said. “As a society, we must protect our children, and the vaccine can do this.”
Read More
There have been 252 vaccine appointments scheduled for children at Excela Health. Representatives for Allegheny Health Network said they did not have data immediately available, but they anticipate high volumes for the next few weeks as parents aim to inoculate kids before the holiday season.
The network will also hold three vaccine events over the next three Saturdays starting Nov. 13 at Allegheny General Hospital before moving to AHN Pediatrics’ Chartiers and Arcadia offices during the following two weeks.
UPMC doctors also discussed data that shows only about a third of pregnant women in the Pittsburgh region are vaccinated against COVID-19, and they urged more expecting mothers to get the shot.
The rates follow national trends, which show about 35% of pregnant people ages 18-49 have received a vaccine, according to data from the Centers for Disease Control and Prevention. Both the CDC and UPMC recommend pregnant people get the vaccine.
The virus remains dangerous to people who are pregnant, while the vaccine has been proven to be safe and effective when used in those who are carrying a baby, said Dr. Richard Beigi, president of UPMC Magee-Womens Hospital. He cited reports that show thousands of women took the vaccine during or before pregnancy and developed no problems with the baby’s health or their own fertility.
“The often mentioned, but completely unsubstantiated, concerns about COVID-19 vaccines causing either miscarriages or other problems with their pregnancy, or causing problems getting pregnant, [are] a complete myth, plain and simple,” Dr. Beigi said at a press conference. “What is not a myth is the harm that COVID-19 can have on pregnant women and their unborn babies.
Dr. Beigi estimated misinformation surrounding the vaccine’s safety has had a negative effect on pregnant people’s willingness to get vaccinated, even as the virus has “devastating effects” on that population if they haven’t gotten the shot.
Fauci on kids vaccine
“These are healthy, young women, otherwise ecstatic to be pregnant — women beaming with joy at the thought of becoming mothers — who are sometimes becoming critically ill with COVID-19,” he said. “This does not need to be this way and does not need to happen.”
Some pregnant women have died due to complications with the virus, he said, while others were so ill at the time of delivering the baby that they were unable to see their newborn until weeks after the birth.
Officials also said they were looking forward to the release of a new antiviral pill, developed by Pfizer Inc., that the company says has been shown to reduce hospitalizations and deaths in vulnerable adults by 90%.
The drugmaker has not yet asked for authorization from the Food and Drug Administration but said it would do so as soon as possible.
“We welcome it. We recognize that the announcement today was from the manufacturer themselves, which always requires, from our perspective, the true validation from the FDA, the CDC and others regarding its effectiveness,” said Tami Minnier, UPMC’s chief quality officer.
Timing of when the pill is authorized is hard to predict, she said, but the health care network is looking forward to more data on the treatment’s effectiveness and its approval by federal regulators.
Mick Stinelli: mstinelli@post-gazette.com; 412-263-1869; and on Twitter: @MickStinelli




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.